Orbimed Advisors - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q4 2022$1,136,658
-32.0%
848,2520.0%0.02%
-29.0%
Q3 2022$1,671,000
+188.1%
848,252
+490.5%
0.03%
+244.4%
Q1 2022$580,000
-63.2%
143,6400.0%0.01%
-55.0%
Q4 2021$1,576,000143,6400.02%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 677,753$7,435,0003.12%
Ghost Tree Capital, LLC 295,000$3,236,0001.16%
GREAT POINT PARTNERS LLC 400,000$4,388,0000.98%
BVF INC/IL 1,791,351$19,651,0000.71%
RA Capital Management 2,282,173$25,035,0000.44%
Cormorant Asset Management, LP 668,854$7,117,0000.42%
RTW INVESTMENTS, LP 2,120,760$23,265,0000.34%
Perceptive Advisors 3,888,228$42,652,0000.33%
Logos Global Management LP 286,652$3,144,0000.32%
HealthCor Management, L.P. 244,838$2,686,0000.15%
View complete list of PYXIS ONCOLOGY INC shareholders